Literature DB >> 21475387

Imaging techniques in the diagnosis of hepatocellular carcinoma and metastatic carcinoma as a result of colon cancer.

Elmar M Merkle1, Janio Szklaruk, Bachir Taouli.   

Abstract

Entities:  

Year:  2010        PMID： 21475387      PMCID： PMC2950625     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.

Authors:  A Li; C S Wong; M K Wong; C M Lee; M C Au Yeung
Journal:  Br J Radiol       Date:  2006-05       Impact factor: 3.039

2.  Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.

Authors:  Takahiro Tsuboyama; Hiromitsu Onishi; Tonsok Kim; Hirofumi Akita; Masatoshi Hori; Mitsuaki Tatsumi; Atsushi Nakamoto; Hiroaki Nagano; Nariaki Matsuura; Kenichi Wakasa; Kaname Tomoda
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

3.  Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters.

Authors:  Mirko Leonhardt; Markus Keiser; Stefan Oswald; Jens Kühn; Jia Jia; Markus Grube; Heyo K Kroemer; Werner Siegmund; Werner Weitschies
Journal:  Drug Metab Dispos       Date:  2010-04-20       Impact factor: 3.922

Review 4.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471
  4 in total
  1 in total

1.  High-spatial and high-temporal resolution dynamic contrast-enhanced perfusion imaging of the liver with time-resolved three-dimensional radial MRI.

Authors:  Ethan K Brodsky; Eric M Bultman; Kevin M Johnson; Debra E Horng; William R Schelman; Walter F Block; Scott B Reeder
Journal:  Magn Reson Med       Date:  2014-03       Impact factor: 4.668
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.